Views & Analysis A new approach to COVID-19 treatment While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus. CEO Dr.
News Bill Anderson will replace Baumann as Bayer CEO Just weeks after Roche pharma chief Bill Anderson resigned to seek other opp
News Welcome to the new pharmaphorum Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved